Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial Investigating the Combination of Pembrolizumab (Keytruda) With Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma

NCT03191981 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT03191981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03191981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial Investigating the Combination of Pembrolizumab (Keytruda) With Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma
Lead sponsor
University of Leeds
Phase
Phase 1/2
Overall status
Withdrawn
Start date
August 1, 2017
Completion date
August 1, 2017
Enrollment
0 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma multiple